Sökning: WFRF:(Sundberg A.) > Multiplexing DNA me...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 06189naa a2200601 4500 | |
001 | oai:DiVA.org:uu-423036 | |
003 | SwePub | |
008 | 201021s2020 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4230362 URI |
024 | 7 | a https://doi.org/10.1172/jci.insight.1365792 DOI |
040 | a (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Neiman, Danielu Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, Hadassah Med Sch, Jerusalem, Israel.4 aut |
245 | 1 0 | a Multiplexing DNA methylation markers to detect circulating cell-free DNA derived from human pancreatic β cells |
264 | c 2020-07-23 | |
264 | 1 | b American Society for Clinical Investigation,c 2020 |
338 | a print2 rdacarrier | |
500 | a Wos title: Multiplexing DNA methylation markers to detect circulating cell-free DNA derived from human pancreatic beta cells | |
520 | a It has been proposed that unmethylated insulin promoter fragments in plasma derive exclusively from β cells, reflect their recent demise, and can be used to assess β cell damage in type 1 diabetes. Herein we describe an ultrasensitive assay for detection of a β cell–specific DNA methylation signature, by simultaneous assessment of 6 DNA methylation markers, that identifies β cell DNA in mixtures containing as little as 0.03% β cell DNA (less than 1 β cell genome equivalent). Based on this assay, plasma from nondiabetic individuals (N = 218, aged 4–78 years) contained on average only 1 β cell genome equivalent/mL. As expected, cell-free DNA (cfDNA) from β cells was significantly elevated in islet transplant recipients shortly after transplantation. We also detected β cell cfDNA in a patient with KATP congenital hyperinsulinism, in which substantial β cell turnover is thought to occur. Strikingly, in contrast to previous reports, we observed no elevation of β cell–derived cfDNA in autoantibody-positive subjects at risk for type 1 diabetes (N = 32), individuals with recent-onset type 1 diabetes (<4 months, N = 92), or those with long-standing disease (>4 months, N = 38). We discuss the utility of sensitive β cell cfDNA analysis and potential explanations for the lack of a β cell cfDNA signal in type 1 diabetes. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Endokrinologi och diabetes0 (SwePub)302052 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Endocrinology and Diabetes0 (SwePub)302052 hsv//eng |
700 | 1 | a Gillis, Davidu Hadassah Hebrew Univ, Endocrine Unit, Dept Pediat, Med Ctr, Jerusalem, Israel.4 aut |
700 | 1 | a Piyanzin, Sheinau Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, Hadassah Med Sch, Jerusalem, Israel.4 aut |
700 | 1 | a Cohen, Danielu Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, Hadassah Med Sch, Jerusalem, Israel.4 aut |
700 | 1 | a Fridlich, Oriu Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, Hadassah Med Sch, Jerusalem, Israel.4 aut |
700 | 1 | a Moss, Joshuau Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, Hadassah Med Sch, Jerusalem, Israel.4 aut |
700 | 1 | a Zick, Aviadu Hadassah Hebrew Univ, Sharett Inst Oncol, Med Ctr, Jerusalem, Israel.4 aut |
700 | 1 | a Oron, Talu Schneider Childrens Med Ctr Israel, Inst Endocrinol & Diabet, Petah Tiqwa, Israel.4 aut |
700 | 1 | a Sundberg, Fridau Sahlgrens Univ Hosp, Queen Silvia Childrens Hosp, Gothenburg, Sweden.4 aut |
700 | 1 | a Forsander, Gunu Sahlgrens Univ Hosp, Queen Silvia Childrens Hosp, Gothenburg, Sweden.4 aut |
700 | 1 | a Skog, Oskar,c Docent, PhD,d 1981-u Uppsala universitet,Klinisk immunologi4 aut0 (Swepub:uu)ossko535 |
700 | 1 | a Korsgren, Olleu Uppsala universitet,Klinisk immunologi4 aut0 (Swepub:uu)ollekors |
700 | 1 | a Levy-Khademi, Florisu Shaare Zedek Med Ctr, Dept Pediat, Jerusalem, Israel.4 aut |
700 | 1 | a Arbel, Danu Hadassah Hebrew Univ, Med Ctr, Pediat Surg, Jerusalem, Israel.4 aut |
700 | 1 | a Hashavia, Saaru Hadassah Hebrew Univ, Med Ctr, Pediat Emergency, Jerusalem, Israel.4 aut |
700 | 1 | a Shapiro, A. M. Jamesu Univ Alberta, Li Ka Shing Ctr Hlth Res Innovat, Edmonton, AB, Canada.4 aut |
700 | 1 | a Speake, Cateu Benaroya Res Inst, Diabet Program, Seattle, WA USA.4 aut |
700 | 1 | a Greenbaum, Carlau Benaroya Res Inst, Diabet Program, Seattle, WA USA.4 aut |
700 | 1 | a Hosford, Jenniferu Univ Florida, Diabet Inst, Dept Pediat, Gainesville, FL 32610 USA.;Univ Florida, Diabet Inst, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA.4 aut |
700 | 1 | a Posgai, Amandau Univ Florida, Coll Med, Gainesville, FL 32610 USA.4 aut |
700 | 1 | a Atkinson, Mark A.u Univ Florida, Diabet Inst, Dept Pediat, Gainesville, FL 32610 USA.;Univ Florida, Diabet Inst, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA.;Univ Florida, Coll Med, Gainesville, FL 32610 USA.4 aut |
700 | 1 | a Glaser, Benjaminu Hadassah Hebrew Univ, Dept Internal Med, Endocrinol & Metab Serv, Med Ctr, Jerusalem, Israel.4 aut |
700 | 1 | a Schatz, Desmond A.u Univ Florida, Diabet Inst, Dept Pediat, Gainesville, FL 32610 USA.;Univ Florida, Diabet Inst, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA.4 aut |
700 | 1 | a Shemer, Ruthu Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, Hadassah Med Sch, Jerusalem, Israel.4 aut |
700 | 1 | a Dor, Yuvalu Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, Hadassah Med Sch, Jerusalem, Israel.4 aut |
710 | 2 | a Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, Hadassah Med Sch, Jerusalem, Israel.b Hadassah Hebrew Univ, Endocrine Unit, Dept Pediat, Med Ctr, Jerusalem, Israel.4 org |
773 | 0 | t JCI Insightd : American Society for Clinical Investigationg 5:14q 5:14x 2379-3708 |
856 | 4 | u http://insight.jci.org/articles/view/136579/files/pdf |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-423036 |
856 | 4 8 | u https://doi.org/10.1172/jci.insight.136579 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy